BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 22, 2015
View Archived Issues
TGR-1202 enters phase I trial in solid tumors
Read More
Pembrolizumab active in patients with advanced biliary tract cancer
Read More
Neurocrine Biosciences begins phase II study of NBI-98854 in Tourette syndrome
Read More
Viking Therapeutics performs safety, tolerability and pharmacokinetic study for VK-5211
Read More
CXCR4-targeted radiotherapy with [177Lu]/[90Y]pentixather could be useful in multiple myeloma
Read More
Foamix initiates phase II trial of FMX-103 in papulopustular rosacea
Read More
Yabao Pharmaceutical licenses second diabetes candidate from Lilly
Read More
Anti-TNF antibody DLX-105 improves symptoms of Behcet's disease
Read More
OPA-15406 shows promise in phase II atopic dermatitis trial
Read More
Vitamin B12-PYY3-36 peptide conjugate reduces food intake in vivo
Read More
S-76892: a promising agent with procognitive and disease modifier properties
Read More
F-17475 is safer and more potent than ketamine in postoperative pain
Read More
Bayer Schering Pharma discloses MMP-12 inhibitors
Read More
X-Rx patents autotaxin inhibitors
Read More
Taisho Pharmaceutical presents orexin receptor antagonists
Read More
Syros Pharmaceuticals divulges CDK7 inhibitors
Read More
Acquisition and licensing agreements expand Novartis' immune-oncology pipeline
Read More
Brighton Biotech acquires license for MERS and SARS vaccines
Read More
Pfizer reports IRAK-4 inhibitors
Read More
Scancell updates pipeline progress
Read More
Biogen reports data from phase III trial of natalizumab in secondary progressive MS
Read More
Femtogenix launched to discover anticancer payloads
Read More
FDA approves Veltassa for hyperkalemia
Read More
AstraZeneca and Lilly expand immuno-oncology combination therapy collaboration
Read More
Autoimmune disease candidate ARGX-113 enters phase I trial in healthy volunteers
Read More